Merit Medical Systems (FRA:MM3) Market Cap: €3,766 Mil (As of Jun. 27, 2026)


FRA:MM3 Merit Medical Systems Inc FRA:MM3
85 GF Score
Price €62.50
GF Value €84.32
Valuation Modestly Undervalued
View Full Analysis

What is Merit Medical Systems Market Cap?

Merit Medical Systems FRA:MM3 +4.17% 85 Market Cap is €3,766 Mil as of Jun. 27, 2026. GuruFocus rates FRA:MM3 with a GF Score™ of 85/100 and a GF Value™ of €84.32 (Modestly Undervalued). Among 866 Medical Devices & Instruments companies, Merit Medical Systems ranks better than 92.73% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Merit Medical Systems's share price for the quarter that ended in Mar. 2026 was €59.5. Merit Medical Systems's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 60 Mil. Therefore, Merit Medical Systems's market cap for the quarter that ended in Mar. 2026 was €3,549 Mil.

Merit Medical Systems's quarterly market cap increased from Sep. 2025 (€4,180 Mil) to Dec. 2025 (€4,397 Mil) but then declined from Dec. 2025 (€4,397 Mil) to Mar. 2026 (€3,549 Mil).

Merit Medical Systems's annual market cap increased from Dec. 2023 (€3,934 Mil) to Dec. 2024 (€5,404 Mil) but then declined from Dec. 2024 (€5,404 Mil) to Dec. 2025 (€4,397 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Merit Medical Systems's Enterprise Value for Today is €4,060 Mil.


Merit Medical Systems  (FRA:MM3) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Merit Medical Systems Market Cap Related Terms


Merit Medical Systems Market Cap Historical Data

* Premium members only.

The historical data trend for Merit Medical Systems's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Merit Medical Systems Market Cap Chart

Merit Medical Systems Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,139.64 3,724.89 3,934.34 5,404.36 4,397.38

Merit Medical Systems Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,760.11 4,648.61 4,179.95 4,397.38 3,549.47

FRA:MM3 vs NVST, MMED, ICUI: Market Cap Comparison

For the Medical Instruments & Supplies subindustry, Merit Medical Systems's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merit Medical Systems Market Cap vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Merit Medical Systems's Market Cap distribution charts can be found below:

* The bar in red indicates where Merit Medical Systems's Market Cap falls into.


FRA:MM3
85GF Score
Merit Medical Systems Inc FRA:MM3
Market Cap is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Merit Medical Systems Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Merit Medical Systems's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as

Market Cap (A: Dec. 2025 )=Share Price (A: Dec. 2025 )*Shares Outstanding (EOP) (A: Dec. 2025 )
=€74*59.424
=€4,397

Merit Medical Systems's Market Cap for the quarter that ended in Mar. 2026 is calculated as

Market Cap (Q: Mar. 2026 )=Share Price (Q: Mar. 2026 )*Shares Outstanding (EOP) (Q: Mar. 2026 )
=€59.5*59.655
=€3,549

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of €3,766 Mil mean?
Merit Medical Systems (FRA:MM3) has a Market Cap of €3,766 Mil as of Jun. 27, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Merit Medical Systems and its competitors. According to the industry distribution chart, Merit Medical Systems ranks #63 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 7.3%.
Is Merit Medical Systems' Market Cap too high?
Merit Medical Systems' current Market Cap is €3,766 Mil. Based on the distribution chart, Merit Medical Systems ranks #63 out of 866 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Merit Medical Systems has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Merit Medical Systems' Market Cap compare to NVST and MMED?
According to the Medical Devices & Instruments industry distribution chart, Merit Medical Systems ranks #63 out of 866 companies for Market Cap. This places Merit Medical Systems in the top 7% of its industry — outperforming the majority of peers. The industry median Market Cap is 121.29. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 121.29, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Merit Medical Systems and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 121.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Merit Medical Systems's current Market Cap is €3,766 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Merit Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Merit Medical Systems (FRA:MM3) is currently considered Modestly Undervalued. The stock's GF Value™ is €84.32, compared to a current price of €62.50 — trading 25.9% below its estimated fair value. The current Market Cap is €3,766 Mil. Merit Medical Systems' overall GF Score™ is 85/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Merit Medical Systems (FRA:MM3), the current Market Cap is €3,766 Mil as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Merit Medical Systems (FRA:MM3) Overvalued in 2026?

Based on GuruFocus' analysis, Merit Medical Systems stock appears to be undervalued. The current stock price of €62.50 is trading 25.9% below its estimated GF Value™ of €84.32. GuruFocus considers Merit Medical Systems to be Modestly Undervalued.

Key valuation signals for FRA:MM3:

  • Market Cap: €3,766 Mil
  • GF Value™: €84.32 vs. price of €62.50 (25.9% below fair value)
  • GF Score™: 85/100

No single metric tells the full story. See the FRA:MM3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Merit Medical Systems Business Description

Other Exchanges MMSI:USA
Address 1600 West Merit Parkway, South Jordan, UT, USA, 84095
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
85GF Score

Get the complete analysis for FRA:MM3

Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€62.50
Price
€84.32
GF Value